Other terms
We discriminated liver injury associated with COVID-19 by temporal
patterns, e.g., admission to the hospital, in-hospital, and cumulative
incidence that took both time points into account. We also linked the
time of illness onset that refers to the onset of symptoms.
Hepatoprotective drugs used in the study included magnesium
isoglycyrrhizinate, diammonium glycyrrhizinate, and polyene
phosphatidylcholine.